Practices in platelet production: A Nordic perspective (2018–2022)
Open Access
- 4 December 2025
- journal article
- Published by Wiley in Vox Sanguinis
- Vol. 121 (3) , 237-244
Abstract
Background and Objectives: The Nordic region includes Denmark, Finland, Iceland, Norway and Sweden, with a population of >27.5 million. Blood services are managed differently in each country. Current data on platelet concentrate ( PC ) production methods and capacity are important for developing efficiency and cross‐border preparedness. Materials and Methods: Retrospective data for 2018–2022 were collected through an online survey sent to all blood centres producing platelets in the region. Questions focused on collection procedures (aphaeresis [ AP ] or whole blood [ WB ]‐derived pools), use of bacterial culture screening ( BCS ) or pathogen reduction ( PR ), shelf‐life, transfusion practices and quality control. Results: A total of 43 blood centres provided data (83% response), including complete national coverage for Sweden, Finland and Iceland. Between 2018 and 2022, 632,596 PCs were produced at participating centres. Annual PC production was stable over the period. Most PCs were WB pools (77%). Automated separation to produce interim platelet unit ( IPU ) pools was performed at 19 centres. PR and BCS were used in 17 and 23 centres, respectively. Shelf‐life ranged from 5 days (no safety measure) to 7 days ( PR or BCS ). The number of PCs transfused in the region declined by ~5% from 2018 to 2022. Conclusion: Platelet production methods, including safety measures to prevent bacterial contamination, varied widely in the Nordic region. Harmonization, including the use of PR or BCS with 7‐day storage, may contribute to resilient platelet supplies in the region.Keywords
Funding Information
- Region Örebro län (OLL‐960569)
This publication has 46 references indexed in Scilit:
- Platelet Additive Solutions and Pathogen Reduction Impact on Transfusion Safety, Patient Management and Platelet SupplyTransfusion Medicine Reviews, 2025
- Using routine health-care data to search for unknown transfusion-transmitted disease: a nationwide, agnostic retrospective cohort studyThe Lancet Digital Health, 2024
- Strengthening health system resilience at the European levelEuropean Journal of Public Health, 2023
- CL-15 Evaluation du risque résiduel de contamination bactérienne dans les concentrés plaquettaires traités par inactivation des pathogènes en FranceTransfusion Clinique et Biologique, 2022
- Platelet Storage Lesions: What More Do We Know Now?Transfusion Medicine Reviews, 2018
- Platelet storage lesion in interim platelet unit concentrates: A comparison with buffy-coat and apheresis concentratesTransfusion and Apheresis Science, 2017
- Serious Hazards of Transfusion (SHOT) haemovigilance and progress is improving transfusion safetyBritish Journal of Haematology, 2013
- Storage of Buffy-coat-derived platelets in additive solutions: in vitro effects on platelets prepared by the novel TACSI system and stored in plastic containers with different gas permeabilityVox Sanguinis, 2010
- Preparation, storage and quality control of platelet concentratesTransfusion and Apheresis Science, 2009
- Variation of platelet production and discard rates in 17 blood centers representing 10 European countries from 2000 to 2002Transfusion, 2006